section name header

Interacting Drugs

OBJECT DRUGS

Ergot Alkaloids:

PRECIPITANT DRUGS

Enzyme Inhibitors:


Comment:

Ergotamine (and probably dihydroergotamine and methysergide) undergo first-pass metabolism by CYP3A4, and several reports of ergotism have appeared when CYP3A4 inhibitors were given concurrently. Theoretically non-oral routes of ergot administration would interact much less than the oral route. Some of these combinations are listed as contraindicated in the product information (e.g., amprenavir or mifepristone with ergot alkaloids).


Class 2: Use Only if Benefit Felt to Outweigh Risk